Physician profile
Jeeshan Ali Faridi
NPI 1134514532
$45,084.21
in general payments reported to CMS, 2019-2025
36 companies · $514 in 2025
The $514 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $27K · 2021: $11K · 2022: $183 · 2023: $1,596 · 2024: $3,401 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,681 · Food and Beverage: $1,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,680.63 |
| Food and Beverage | $1,830.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,972.26 | 2020-2025 | |
| Fortis Surgical, LLC | $6,938.88 | 2020-2021 | |
| Djo, LLC | $3,750.00 | 2020-2021 | |
| Smith+Nephew, INC. | $2,767.78 | 2020-2023 | Renasys Touch, Renasys Go V2 Home, Pico |
| Zimmer Biomet Holdings, INC. | $1,244.36 | 2023 | Comprehensive Shoulder System, Persona, Juggerknotless Soft Anchor |
| Alpha Orthopedic Systems | $1,166.86 | 2020-2024 | |
| Stryker Corporation | $903.27 | 2019-2023 | Alphavent |
| Blue Surgical LLC | $832.07 | 2024 | |
| Linvatec Corporation | $500.00 | 2020 | |
| Depuy Synthes Sales INC. | $178.07 | 2019-2024 | Tfn-Advance, Monovisc |
| Piedmont Plus Innovation | $99.94 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $78.56 | 2022-2025 | Zilretta |
| Electronic Waveform Lab, INC. | $56.54 | 2021 | |
| Heron Therapeutics, INC. | $54.10 | 2023 | Zynrelef |
| Acumed LLC | $47.19 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $47.14 | 2023-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Heraeus Medical, LLC. | $35.94 | 2022-2024 | |
| Medacta USA, INC. | $35.51 | 2019 | |
| Treace Medical Concepts, INC. | $31.12 | 2023 | |
| Amgen INC. | $28.23 | 2024 | Evenity, Prolia |
| Medartis INC. | $27.38 | 2021-2024 | Aptus |
| Avanos Medical | $26.87 | 2024 | Coolief* Cooled Radiofrequency |
| Tactile Systems Technology INC | $25.15 | 2023 | Flexitouch Plus, Entre Plus |
| Abbvie INC. | $24.42 | 2022 | |
| Ethicon US, LLC | $24.13 | 2019 | |
| Zimvie INC. | $22.48 | 2023 | |
| Orthofix Medical, INC. | $21.68 | 2019-2020 | |
| Ermi LLC | $20.99 | 2022 | |
| Pacira Therapeutics, INC. | $19.90 | 2019 | |
| Vericel Corporation | $17.60 | 2020 | |
| Allergan, INC. | $16.32 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.31 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.61 | 2023 | Euflexxa |
| Pfizer INC. | $14.21 | 2022 | |
| Kerecis Limited | $14.12 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mallinckrodt Enterprises LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeeshan Faridi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.